VanEck Biotech ETF
BBH
84 hedge funds and large institutions have $78M invested in VanEck Biotech ETF in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 28 reducing their positions, and 13 closing their positions.
1,059% more call options, than puts
Call options by funds: $10M | Put options by funds: $865K
0.91% more ownership
Funds ownership: 19.62% → 20.54% (+0.91%)
3% less capital invested
Capital invested by funds: $80.7M → $78M (-$2.69M)
7% less funds holding
Funds holding: 90 → 84 (-6)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
71% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.44M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.13M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$992K |
| 4 |
B
Bailard
Foster City,
California
|
+$200K |
| 5 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
+$199K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$2.75M |
| 2 |
Morgan Stanley
New York
|
-$1.21M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.08M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$864K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$519K |
BBH Hedge Fund Activity: Q2 2019 in Review
84 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2019, worth a combined $78M — down 3.3% from $80.7M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of BBH and 11 opened new positions — a net loss of 2 holders — while 28 trimmed existing stakes and 8 added.
The largest buyer was Susquehanna International Group, adding an estimated $3.44M. The largest seller was Virtu Financial, exiting entirely with an estimated $2.75M sold.
- 84 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2019, down from 90 in Q1 2019.
- Funds reported $78M of VanEck Biotech ETF stock for Q2 2019, down 3.3% quarter-over-quarter.
- 11 funds opened new VanEck Biotech ETF positions in Q2 2019 and 13 closed out, a net change of -2 holders.
- The largest VanEck Biotech ETF buyer in Q2 2019 was Susquehanna International Group, an estimated $3.44M added.
- The largest VanEck Biotech ETF seller in Q2 2019 was Virtu Financial, an estimated $2.75M sold.
Based on aggregated 13F filings for Q2 2019.